Showing results (21-30 of 130) with videos related to
Sort By:
Pageof 13
Future Oncology (London, England)|May 23, 2022
Momelotinib for the treatment of myelofibrosis with anemiaDouglas Tremblay, Ruben MesaExpert Opinion on Pharmacotherapy|March 16, 2023
Pharmacotherapeutic advances for splenomegaly in myelofibrosisDouglas Tremblay, John MascarenhasInternational Journal of Hematology|February 19, 2022
Novel treatments for myelofibrosis: beyond JAK inhibitorsDouglas Tremblay, Ruben MesaCurrent Hematologic Malignancy Reports|February 9, 2020
Novel Therapies in Polycythemia VeraDouglas Tremblay, John MascarenhasCells|April 30, 2021
Next Generation Therapeutics for the Treatment of MyelofibrosisDouglas Tremblay, John MascarenhasBest Practice & Research. Clinical Haematology|November 4, 2022
Addressing symptom burden in myeloproliferative neoplasmsDouglas Tremblay, Ruben MesaNeurosurgical Focus|June 1, 2024
Outcomes, complications, and dosing of intrathecal baclofen in the treatment of multiple sclerosis: a systematic reviewFrancesca M Cozzi, David Zuckerman, Ariel Sacknovitz, et al.Leukemia & Lymphoma|October 25, 2024
Adoptive cell therapy in acute myeloid leukemia: the current landscape and emerging strategiesSerena Tharakan, Douglas Tremblay, Jacques AzziActa Haematologica|April 7, 2021
The Efficacy of Etoposide-Based Therapy in Adult Secondary Hemophagocytic LymphohistiocytosisLeonard Naymagon, Douglas Tremblay, John MascarenhasBlood Reviews|July 31, 2023
The core concepts of core binding factor acute myeloid leukemia: Current considerations for prognosis and treatmentChristina Darwish, Kyle Farina, Douglas TremblayPageof 13